Next Article in Journal
Investigation of Volatiles in Cork Samples Using Chromatographic Data and the Superposing Significant Interaction Rules (SSIR) Chemometric Tool
Next Article in Special Issue
Hypoxia as a Driving Force of Pluripotent Stem Cell Reprogramming and Differentiation to Endothelial Cells
Previous Article in Journal
Differential Anti-Proliferative and Anti-Migratory Activities of Ursolic Acid, 3-O-Acetylursolic Acid and Their Combination Treatments with Quercetin on Melanoma Cells
Previous Article in Special Issue
Ticagrelor Prevents Endothelial Cell Apoptosis through the Adenosine Signalling Pathway in the Early Stages of Hypoxia
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Biomolecules
Volume 10
Issue 6
10.3390/biom10060895
biomolecules-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

IRE1 Endoribonuclease Activity Modulates Hypoxic HIF-1α Signaling in Human Endothelial Cells

by
Adrianna Moszyńska
1,*,
James F. Collawn
2 and
Rafal Bartoszewski
1,*
1
Department of Biology and Pharmaceutical Botany, Medical University of Gdansk, 80210 Gdansk, Poland
2
Department of Cell, Developmental and Integrative Biology, University of Alabama at Birmingham, Birmingham, AL 35294, USA
*
Authors to whom correspondence should be addressed.
Biomolecules 2020, 10(6), 895; https://doi.org/10.3390/biom10060895
Submission received: 27 May 2020 / Revised: 6 June 2020 / Accepted: 7 June 2020 / Published: 11 June 2020
(This article belongs to the Special Issue Hypoxia and Hypoxia-Inducible Factors in Human Endothelium)
Browse Figures
Versions Notes

Abstract

While the role of hypoxia and the induction of the hypoxia inducible factors (HIFs) and the unfolded protein response (UPR) pathways in the cancer microenvironment are well characterized, their roles and relationship in normal human endothelium are less clear. Here, we examined the effects of IRE1 on HIF-1α protein levels during hypoxia in primary human umbilical vein endothelial cells (HUVECs). The results demonstrated that HIF-1α levels peaked at 6 h of hypoxia along with two of their target genes, GLUT1 and VEGFA, whereas at up to 12 h of hypoxia the mRNA levels of markers of the UPR, IRE1, XBP1s, BiP, and CHOP, did not increase, suggesting that the UPR was not activated. Interestingly, the siRNA knockdown of IRE1 or inhibition of IRE1 endonuclease activity with 4µ8C during hypoxia significantly reduced HIF-1α protein without affecting HIF1A mRNA expression. The inhibition of the endonuclease activity with 4µ8C in two other primary endothelial cells during hypoxia, human cardiac microvascular endothelial cells and human aortic endothelial cells showed the same reduction in the HIF-1α protein. Surprisingly, the siRNA knockdown of XBP1s during hypoxia did not decrease the HIF1α protein levels, indicating that the IRE1-mediated effect on stabilizing the HIF1α protein levels was XBP1s-independent. The studies presented here, therefore, provide evidence that IRE1 activity during hypoxia increases the protein levels of HIF1α in an XBP1s-independent manner.
Keywords:
RIDD; HIF1A; XBP1; ERN1; hypoxia

1. Introduction

In order to adjust to stress conditions, cells undergo critical adaptive responses during hypoxia. This includes the up-regulation of hypoxia-inducible factors (HIFs) and potentially the induction of the unfolded protein response (UPR). The UPR pathway consists of distinct signaling axes that are mediated by three endoplasmic reticulum (ER) transmembrane stress sensors: activating transcription factor 6 (ATF6), protein kinase RNA-like endoplasmic reticulum kinase (PERK) and Inositol-requiring transmembrane kinase/endoribonuclease 1α (IRE1α) [1,2,3]. The activation of this pathway protects the cell against protein misfolding during hypoxia [4,5,6,7,8,9,10,11]. Despite the importance of both HIFs and the UPR pathway for the cancer microenvironment and cardiovascular disorders, the relationship between the HIFs and the UPR is poorly understood, especially in the normal human endothelium [12]. Although the HIF-dependent activation of the PERK axes has been reported in both cancer and normal cells [4,13], the hypoxic activation of ATF6 and IRE1 signaling remains ambiguous. Notably, the UPR during unmitigated stress directs cells toward apoptosis, whereas the IRE1 axes serve as a molecular timer for the cell fate decision process. The activation of IRE1α leads to the reduction of protein synthesis through regulated IRE1-dependent decay (RIDD), which results in the degradation of selected mRNAs [14]. Additionally, the active spliced isoform of the X-box binding-protein transcription factor (XBP1s) is formed by the endoribonuclease activity of IRE1α [15], facilitating cell survival and increasing the ER’s folding capacity [15,16,17]. Furthermore, the inflammatory response and activation of autophagy and apoptosis processes led by Janus N-terminal kinase (JNK) is achieved by IRE1α kinase activity [14,18]. Although it is feasible that IRE1 signaling could also be important during hypoxia for cell survival, the activation of this pathway and its relation to HIF signaling is virtually unknown. To date, both hypoxic induction and the impairment of XBP1s have been reported in cancer cell lines [19,20,21,22,23,24,25,26,27,28], whereas IRE1-related activity that did not result in XBP1s accumulation was observed in human endothelium [29].
In this study, we have focused on the consequences of IRE1 activation on HIF-1α levels during hypoxia in human primary endothelial cells. Our findings reveal that the impairment of IRE1 activity results in reduced HIF-1α protein levels that are independent of XBP1s. Our results suggest that regulated IRE1-dependent decay of mRNA (RIDD) is an important regulator of HIF-1α protein expression during hypoxia.

2. Materials and Methods

2.1. Cell Culture

Primary human umbilical vein endothelial cells (HUVECs) (#ZHC-2301) were obtained from Cellworks and cultured in EGM-2 Endothelial Cell Growth Medium-2 BulletKit (Lonza, Visp, Switzerland). Primary human aortic ECs (HAECs) were purchased from Lonza and cultured in EGM-2 medium. Primary human cardiac microvascular ECs (HMVECs-C) were also purchased from Lonza and cultured in EGM-2MV medium. All experiments were conducted at passage 4 at a confluence of 80%. Cells were cultured in a humidified incubator (Thermo Scientific, Waltham, MA, USA) at 37 °C in 5% CO2 in T75 culture flasks (Falcon) before plating them into smaller culture dishes (35 or 60 mm) for RNA or protein isolation, respectively.

2.2. Hypoxia Induction

Hypoxia was induced in a physiological cell culture workstation InvivO2 (Baker Ruskin, FL, USA) designed for hypoxia research. Both the media and workstation were pre-equilibrated for 2 h prior to the experiments. Cells were maintained at 0.9% O2 for the time periods specified (PO2 was 10–12 mm Hg) [30,31]. At the same time, control cells were maintained in normoxia inside a CO2/O2 incubator (Thermo Scientific).

2.3. IRE1α Inhibition

Cells were treated for 6 h in normoxia or hypoxia with 20 µM final concentration of 4µ8C (Sigma-Aldrich) dissolved in DMSO (Sigma-Aldrich, St. Louis, MI, USA).

2.4. siRNA Transfection

HUVECs were transfected using Lipofectamine RNAiMAX (Thermo Scientific) according to the manufacturer’s protocol. All siRNAs (Ambion, Austin, TX, USA) were used at a final concentration of 40 nM: XBP1 (ID s14915), ERN1 (ID s200432), and Negative Control No. 1 (#4390843). After 24 h, the transfected cells were put into a hypoxia chamber for 6 h, whereas the control cells remained in an incubator with normoxic conditions.

2.5. RNA Isolation

Total RNA (containing both mRNA and microRNA) was isolated using a miRNeasy Mini Kit (Qiagen, Hilden, Germany). RNA concentrations were calculated based on the absorbance at 260 nm. RNA samples were stored at −70 °C until use.

2.6. Real Time PCR (qRT-PCR)

The TaqMan RNA-to-Ct 1-Step Kit (Thermo Scientific) was used following the manufacturer’s protocol. The relative mRNA expression levels were calculated using the 2-ΔΔCt method [32] with the 18S and RPLP0 genes as the reference genes [33]. The TaqMan Assay IDs were: 18S (Hs99999901_s1); DDIT3 [alias CHOP] (Hs00358796_m1); ERN1 [IRE1α gene] (Hs00176385_m1); HIF1A (Hs00153153_m1); HSPA5 [alias BiP] (Hs00607129_gH); RPLP0 (Hs00420895_gH); SLC2A1 [GLUT1 gene] (Hs00892681_m1); VEGFA (Hs00900055_m1); XBP1 (Hs00231936_m1); and XBP1s (Hs03929085_g1).

2.7. Western Blot Analyses

Western Blot analysis was performed as previously described [34]. Following the normalization of protein concentrations, the lysates were mixed with an equal volume of 6X Laemmli sample buffer (12% SDS, 60% glycerol, 0.06% bromophenol blue, 375 mM Tris-HCl pH = 6.8) and incubated for 5 min at 95 °C prior to separation by SDS-PAGE on a 4–15% Criterion TGX Stain-Free Gel (Bio-Rad, Hercules, CA, USA). Following SDS-PAGE, the proteins were transferred to polyvinylidene fluoride membranes (Bio-Rad) using the wet electroblotting method (300 mA, 4 °C, 90 min for one gel and 180 min for two gels). The membranes were blocked with BSA dissolved in TBS/Tween-20 (3% BSA, 0.5% Tween-20 for 1 h), followed by immunoblotting with the primary antibodies (overnight, 4 °C): mouse anti–HIF-1α (1:2000, ab16066; Abcam) and rabbit anti–β-actin (1:1000, ab1801; Abcam). After the washing steps, the membranes were incubated with goat anti-rabbit IgG (heavy and light chains) or with goat anti-mouse IgG (heavy and light chains) horseradish peroxidase-conjugated secondary antibodies (Bio-Rad) for 1 h at room temperature and detected using SuperSignal West Pico ECL (Thermo Scientific). Densitometry was performed using the Image Lab software v.4.1 (Bio-Rad).

2.8. Statistical Analysis

Results were expressed as means ± standard error (SEM). Statistical significance was determined using the Student’s t test (one-tailed, homoscedastic), with p < 0.05 considered significant.

3. Results

To determine when the exposure of human endothelial cells to acute hypoxia results in UPR IRE1 pathway activation, we performed a time-course study and monitored the classic UPR proadaptive and apoptotic mRNA markers in primary human endothelial cells. Primary HUVECs (pooled from 10 independent donors) were exposed to hypoxia (0.9% O2) for up to 24 h, and HIF-1α protein levels were measured at the specified time points. As shown in Figure 1A, HIF-1α levels peaked at 6 h, and although they were reduced at 12 h and 24 h, they remained elevated during the entire 24 h time course compared to the normoxic control. The hypoxic accumulation of HIF-1α was also indicated by HIF-1 activity that resulted in the induction of mRNA for two of its transcriptional targets, the glucose transporter protein type 1 (GLUT1 (SLCA2A1)) mRNA and vascular endothelial growth factor A (VEGFA) mRNA (Figure 1B,C). These results that confirm the hypoxic activation of HIF-1 signaling in HUVECs are in good agreement with previous studies including our own [34,35,36,37,38,39,40]. Surprisingly, the luminal endoplasmic reticulum protein BiP (HSPA5) mRNA levels, a UPR pro-adaptive activation marker [41,42,43,44], were reduced after 12 h of exposure to hypoxia (Figure 1D), while the mRNA levels of apoptotic C/EBP homologous protein (CHOP (DDIT3)) [41,43,44,45] were elevated only after 24 h of exposure to hypoxia (Figure 1E). Thus, the exposure of HUVECs to hypoxia did not result in ER stress and the subsequent activation of UPR signaling during the earlier time points of up to 12 h.
Based on previous reports that postulated that XBP1s, a product of the UPR IRE1 activation pathway, could potentiate the HIF-1-dependent induction of VEGF mRNA [46,47,48,49], we followed IRE1 (ERN1) and XBP1 mRNA levels. As shown in Figure 2A, IRE1 mRNA levels did not increase during the first 12 h, and total XBP1 mRNA only went down after 24 h (Figure 2B), whereas XBP1s was significantly downregulated after 6 h and throughout the rest of the time course (Figure 2C).
Since this result suggested that hypoxia may prevent XBP1s signaling, we assessed the consequences of inactivation of the IRE1 pathway on HIF-1α accumulation during hypoxia. Using siRNA inhibition, we impaired IRE1 mRNA expression by about 50% (Figure 3A) and followed HIF-1α protein and mRNA levels in HUVECs cultured in normoxia and exposed to hypoxia for 6 h, a time at which there was a maximal accumulation of HIF-1α protein. Interestingly, IRE1 silencing resulted in a dramatic reduction of HIF-1α protein accumulation in hypoxia (Figure 3B), while the hypoxic HIF1A mRNA levels remained relatively unaffected (Figure 3C). This suggested that IRE1 was somehow contributing to the accumulation of HIF-1α during hypoxia.
To test the idea that IRE1 RIDD activity mediated this effect, we used a specific inhibitor of RIDD activity: 4µ8C [50] (Figure 4A). As shown in Figure 4B, in the HUVECs that were treated with 4µ8C and exposed to hypoxia, HIF-1α protein levels were reduced in a similar manner as in the cells with IRE1 knockdown, while the HIF1A mRNA levels remained unchanged (Figure 4C). Notably, the 4µ8C was effectively inhibiting IRE1 endoribonuclease activity, both in normoxia and hypoxia, and thus significantly reducing XBP1s mRNA levels (Figure 4D), without affecting total XBP1 expression (Figure 4E). This suggested that IRE1 was active in both normoxia and hypoxia. Furthermore, despite XBP1s mRNA reduction during hypoxia, this transcription factor may still be crucial for hypoxic HIF-1α stabilization.
Therefore, to test this, we efficiently knocked down XBP1s expression with specific siRNA, during both normoxic and hypoxic conditions (Figure 5A) and followed related HIF-1α protein and mRNA levels. As shown in Figure 5B,C, XBP1s silencing had no effect on HIF-1α protein or mRNA levels respectively. Therefore, although IRE1-RIDD activity leads to the accumulation of HIF-1α protein in human endothelial cells exposed to hypoxia, this process is XBP1s-independent.
Finally, we also confirmed the role of IRE1 RIDD activity in HIF-1α accumulation during hypoxia in other primary endothelial human cell lines, including human cardiac microvascular endothelial cells (HMVEC-C) and human aortic endothelial cells (HAEC), where inhibiting IRE1 activity resulted in the dramatic reduction of hypoxic HIF-1α protein (Figure 6A,B).
Taken together, our data show that although the exposure of primary endothelial cells to acute hypoxia does not activate typical UPR signaling during the early time points, the RIDD activity of IRE1 potentiates hypoxic HIF-1α protein accumulation in an XBP1s-independent manner.

4. Discussion

Despite the development of novel therapeutic approaches against human cardiovascular and cancer diseases, effective interventions will require determining the mechanisms that regulate cell fate decisions during cellular stress conditions. The problem, however, is that the molecular crosstalk between these pathways remains largely unexplained and limited to cancer cell models [51,52,53,54,55,56,57]. Notably, despite the fact that hypoxia has been reported to activate UPR signaling in order to modulate cancer progression [5,54,58,59], the cancer cell-based models often rely on unique genetic and epigenetic modifications that allow these cells to bypass cell fate decisions during both hypoxia and the UPR. Consequently, deciphering the universal molecular connection between these adaptive responses is very challenging. However, the parallel studies in normal endothelial cells that undergo angiogenesis provide the main adaptive response to an unmet oxygen demand and these types of studies remain underappreciated.
In our approach, we utilized hypoxia-exposed primary HUVECs from 10 pooled donors to determine the role of the ER stress on the HIF-1 signaling pathway. Despite the fact that previous studies reported the hypoxia-related induction of BIP expression [7,60,61,62], we found that BiP mRNA levels were reduced after a 12 h exposure to hypoxia. Furthermore, the significant accumulation of apoptotic CHOP (DDIT3) mRNA was observed only in cells exposed to hypoxia for 24 h. Although CHOP accumulation and the potential induction of an apoptotic response were observed in some hypoxia experiments (including lung endothelial cells) [63,64], these protein and mRNA levels were much lower than those observed during ER stress [19]. Furthermore, we did not observe the accumulation of XBP1s that could have suggested the UPR-related activation of IRE1 signaling.
Although we did not test for PERK activation, PERK-mediated eIF2 phosphorylation that could lead to global translational repression was observed in HUVECs within minutes after exposure to acute hypoxia (below 0.1% O2), whereas this reaction rate continuously declined with increasing oxygen concentrations [19]. Furthermore, PERK-mediated eIF2 phosphorylation was totally deactivated after 16 h of hypoxia [19]. In our model, we used 0.9% O2 and prolonged exposure to hypoxia, and therefore PERK involvement is unlikely. Taken together, our data clearly demonstrate that in HUVECs exposed to hypoxia for up to 12 h, there is no activation of a classical adaptive or apoptotic UPR that could potentially modulate the HIF-1 signals.
Notably, we observed that the hypoxia exposure resulted in early and significantly lower levels of IRE1-processed XBP1s mRNA that did not correlate with any significant reduction in the total XBP1 mRNA expression at 6 h and 12 h. To date, although the accumulation of XBP1s was reported in cancer cell lines exposed to acute and moderate hypoxia [19,20,21,22,23,24,25,26,27], the impairment of XBP1 splicing under acute hypoxia was also reported [28]. Notably, support for our results came from the study in human pulmonary artery smooth muscle cells (PASMCs) that demonstrated that despite IRE1-related activity, there was no hypoxia-induced XBP1s protein accumulation [29].
Our follow up analysis of IRE1′s role during hypoxia revealed that silencing of this gene paradoxically attenuated HIF-1α accumulation, without apparently affecting HIF1A mRNA levels. This observation was further verified by the specific inhibition of IRE1 endoribonuclease activity and supported our view that IRE1′s RIDD activity plays an important role in HIF-1α protein accumulation during hypoxia. Importantly, consistent with the observed hypoxic decline in XBP1s mRNA levels, the silencing of XBP1s expression during hypoxia has no effect on HIF-1α protein nor mRNA. Although hypoxia did not result in the activation of the classical UPR signaling pathway and XBP1 expression induction, it is plausible that these transcription factor effects on hypoxic signaling in normal endothelial cells are marginal. Taken together, the data indicate that IRE1 endoribonuclease activity is potentiating hypoxia accumulation of HIF-1α utilizing posttranscriptional pathways that are independent of XBP1s. Furthermore, although hypoxia-related changes in redox balance could affect IRE1 activity, previous studies have shown that oxidative stress attenuates UPR signaling by preventing IRE1 endoribonuclease activity [65]. Therefore, although we cannot exclude ROS-related modifications of IRE1 in our model, these modifications are most likely not related to the observed changes in HIF-1α levels.
Furthermore, it needs to be noted that most ER stress and UPR studies are based on the use of high concentrations of pharmacological ER stressors that result in the potent activation of all UPR pathways at both the transcriptional and posttranscriptional levels [2,41,66]. This is in contrast to the biological role and the extent of the biological activity of PERK and IRE1 in low stress conditions which are relatively unknown. Therefore, we cannot exclude the possibility that although it was not reflected in UPR marker mRNA level measurements, our hypoxia induction over the 12 h period and the related HIF-1 signaling disturbed ER homeostasis, and this led to BIP dissociation from ER membrane and activation of some of the IRE1 and PERK activity, although at much more modest levels than during pharmacological ER stress.
Taken together, although the results presented here provide an important and novel link for IRE1 endoribonuclease activity and HIF-1 signaling during hypoxia in human endothelial cells, the related molecular mechanisms governing IRE1 endoribonuclease hypoxic activity will require further study. We can speculate that during hypoxia, IRE1 activity may support HIF-1α accumulation by degrading specific microRNAs or other RNAs that could lead to HIF-1α translational inhibition in a similar manner as IRE1 mediates the decay of anti-apoptotic microRNAs during the UPR [67]. However, further extensive studies are required to understand IRE1’s role in normal and hypoxic conditions before this hypothesis can be validated.
Finally, we also confirmed the role of IRE1 activity in HIF-1α accumulation during hypoxia in other primary human endothelial cells lines including human cardiac microvascular endothelial cells (HMVEC-C) and human aortic endothelial cells (HAEC), and showed that impairment of RIDD resulted in a dramatic reduction of HIF-1α protein in these cells as well.

5. Conclusions

In summary, we demonstrated that IRE1 endoribonuclease activity is necessary for efficient HIF-1α accumulation in hypoxia-exposed human endothelial cells. However, further studies will be necessary to define the mechanism underlying the molecular relationship between these factors and how they modulate HIF-1-dependent adaptation to low oxygen pressure. The studies presented here have identified IRE1 as a novel player involved in hypoxic HIF-1 signaling.

Author Contributions

Conceptualization, A.M. and R.B.; methodology, A.M.; investigation, A.M.; writing—original draft preparation, A.M.; writing—review and editing, R.B. and J.F.C.; supervision and project administration, R.B.; funding acquisition, R.B. and J.F.C. All authors have read and agreed to the published version of the manuscript.

Funding

This research was funded by the National Science Center Sonata Bis Program under contract 2015/18/E/NZ3/00687 (to R.B.) and by the NIH P30 DK072482 grant and the Research Development Program (ROWE15R0) from the CF Foundation (to J.F.C.).

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Walter, P.; Ron, D. The Unfolded Protein Response: From Stress Pathway to Homeostatic Regulation. Science 2011, 334, 1081–1086. [Google Scholar] [CrossRef] [PubMed]
  2. Bravo, R.; Parra, V.; Gatica, D.; Rodriguez, A.E.; Torrealba, N.; Paredes, F.; Wang, Z.V.; Zorzano, A.; Hill, J.A.; Jaimovich, E.; et al. Endoplasmic Reticulum and the Unfolded Protein Response: Dynamics and Metabolic Integration. Int. Rev. Cell Mol. Boil. 2013, 301, 215–290. [Google Scholar] [CrossRef]
  3. Karagoz, G.E.; Acosta-Alvear, D.; Walter, P. The Unfolded Protein Response: Detecting and Responding to Fluctuations in the Protein-Folding Capacity of the Endoplasmic Reticulum. Cold Spring Harb. Perspect. Boil. 2019, 11. [Google Scholar] [CrossRef] [PubMed]
  4. Bensellam, M.; Maxwell, E.L.; Chan, J.Y.; Luzuriaga, J.; West, P.K.; Jonas, J.C.; Gunton, J.E.; Laybutt, D.R. Hypoxia reduces ER-to-Golgi protein trafficking and increases cell death by inhibiting the adaptive unfolded protein response in mouse beta cells. Diabetologia 2016, 59, 1492–1502. [Google Scholar] [CrossRef] [PubMed]
  5. Wouters, B.G.; Koritzinsky, M. Hypoxia signalling through mTOR and the unfolded protein response in cancer. Nat. Rev. Cancer 2008, 8, 851–864. [Google Scholar] [CrossRef]
  6. Maamoun, H.; Benameur, T.; Pintus, G.; Munusamy, S.; Agouni, A. Crosstalk Between Oxidative Stress and Endoplasmic Reticulum (ER) Stress in Endothelial Dysfunction and Aberrant Angiogenesis Associated With Diabetes: A Focus on the Protective Roles of Heme Oxygenase (HO)-1. Front. Physiol. 2019, 10. [Google Scholar] [CrossRef] [PubMed]
  7. Binet, F.; Sapieha, P. ER Stress and Angiogenesis. Cell Metab. 2015, 22, 560–575. [Google Scholar] [CrossRef] [PubMed]
  8. Martinez, J.A.; Banerjee, D.K. Tunicamycin inhibits angiogenesis by ER stress. Glycobiology 2000, 10, 1131. [Google Scholar]
  9. Thiele, R.H. Subcellular Energetics and Metabolism: A Cross-Species Framework. Anesth. Analg. 2017, 124, 1857–1871. [Google Scholar] [CrossRef]
  10. Bartoszewski, R.; Kroliczewski, J.; Piotrowski, A.; Jasiecka, A.J.; Bartoszewska, S.; Vecchio-Pagan, B.; Fu, L.; Sobolewska, A.; Matalon, S.; Cutting, G.R.; et al. Codon bias and the folding dynamics of the cystic fibrosis transmembrane conductance regulator. Cell. Mol. Biol. Lett. 2016, 21, 23. [Google Scholar] [CrossRef]
  11. Bartoszewski, R.; Rab, A.; Fu, L.; Bartoszewska, S.; Collawn, J.; Bebok, Z. CFTR expression regulation by the unfolded protein response. Methods Enzym. 2011, 491, 3–24. [Google Scholar] [CrossRef]
  12. Bartoszewska, S.; Collawn, J.F. Unfolded protein response (UPR) integrated signaling networks determine cell fate during hypoxia. Cell Mol. Biol. Lett. 2020, 25, 18. [Google Scholar] [CrossRef]
  13. Wang, Y.; Alam, G.N.; Ning, Y.; Visioli, F.; Dong, Z.; Nor, J.E.; Polverini, P.J. The unfolded protein response induces the angiogenic switch in human tumor cells through the PERK/ATF4 pathway. Cancer Res. 2012, 72, 5396–5406. [Google Scholar] [CrossRef] [PubMed]
  14. Han, D.; Lerner, A.G.; Vande Walle, L.; Upton, J.P.; Xu, W.H.; Hagen, A.; Backes, B.J.; Oakes, S.A.; Papa, F.R. IRE1 alpha Kinase Activation Modes Control Alternate Endoribonuclease Outputs to Determine Divergent Cell Fates. Cell 2009, 138, 562–575. [Google Scholar] [CrossRef]
  15. Yoshida, H.; Matsui, T.; Yamamoto, A.; Okada, T.; Mori, K. XBP1 mRNA is induced by ATF6 and spliced by IRE1 in response to ER stress to produce a highly active transcription factor. Cell 2001, 107, 881–891. [Google Scholar] [CrossRef]
  16. Bartoszewska, S.; Cabaj, A.; Dabrowski, M.; Collawn, J.F.; Bartoszewski, R. miR-34c-5p modulates X-box-binding protein 1 (XBP1) expression during the adaptive phase of the unfolded protein response. FASEB J. 2019, 33, 11541–11554. [Google Scholar] [CrossRef]
  17. Bartoszewski, R.; Brewer, J.W.; Rab, A.; Crossman, D.K.; Bartoszewska, S.; Kapoor, N.; Fuller, C.; Collawn, J.F.; Bebok, Z. The Unfolded Protein Response (UPR)-activated Transcription Factor X-box-binding Protein 1 (XBP1) Induces MicroRNA-346 Expression That Targets the Human Antigen Peptide Transporter 1 (TAP1) mRNA and Governs Immune Regulatory Genes. J. Boil. Chem. 2011, 286, 41862–41870. [Google Scholar] [CrossRef]
  18. Urano, F.; Wang, X.Z.; Bertolotti, A.; Zhang, Y.H.; Chung, P.; Harding, H.P.; Ron, D. Coupling of stress in the ER to activation of JNK protein kinases by transmembrane protein kinase IRE1. Science 2000, 287, 664–666. [Google Scholar] [CrossRef] [PubMed]
  19. Koumenis, C.; Naczki, C.; Koritzinsky, M.; Rastani, S.; Diehl, A.; Sonenberg, N.; Koromilas, A.; Wouters, B.G. Regulation of protein synthesis by hypoxia via activation of the endoplasmic reticulum kinase PERK and phosphorylation of the translation initiation factor eIF2alpha. Mol. Cell. Biol. 2002, 22, 7405–7416. [Google Scholar] [CrossRef] [PubMed]
  20. Xia, Z.X.; Wu, S.Y.; Wei, X.; Liao, Y.F.; Yi, P.; Liu, Y.; Liu, J.M.; Liu, J.F. Hypoxic ER stress suppresses beta-catenin expression and promotes cooperation between the transcription factors XBP1 and HIF1 alpha for cell survival. J. Boil. Chem. 2019, 294, 13811–13821. [Google Scholar] [CrossRef]
  21. Liang, H.C.; Zhou, Z.M.; Chen, C.S. Hypoxia induces miR-153 through the IRE1 alpha-XBP1 pathway to fine-tune the HIF1 alpha/VEGFA axis in breast cancer angiogenesis. Cancer Res. 2018, 78. [Google Scholar] [CrossRef]
  22. Liang, H.C.; Xiao, J.; Zhou, Z.M.; Wu, J.; Ge, F.; Li, Z.C.; Zhang, H.L.; Sun, J.; Li, F.B.; Liu, R.; et al. Hypoxia induces miR-153 through the IRE1 alpha-XBP1 pathway to fine tune the HIF1 alpha/VEGFA axis in breast cancer angiogenesis. Oncogene 2018, 37, 1961–1975. [Google Scholar] [CrossRef] [PubMed]
  23. Chen, X.; Iliopoulos, D.; Zhang, Q.; Tang, Q.Z.; Greenblatt, M.B.; Hatziapostolou, M.; Lim, E.; Tam, W.L.; Ni, M.; Chen, Y.W.; et al. XBP1 promotes triple-negative breast cancer by controlling the HIF1 alpha pathway. Nature 2014, 508, 103. [Google Scholar] [CrossRef] [PubMed]
  24. Xu, X.D.; Qimuge, A.D.; Wang, H.L.; Xing, C.; Gu, Y.; Liu, S.S.; Xu, H.; Hu, M.R.; Song, L. IRE1 alpha/XBP1s branch of UPR links HIF1 alpha activation to mediate ANGII-dependent endothelial dysfunction under particulate matter (PM) 2.5 exposure. Sci. Rep. 2017, 7. [Google Scholar] [CrossRef]
  25. Romero-Ramirez, L.; Cao, H.B.; Nelson, D.; Hammond, E.; Lee, A.H.; Yoshida, H.; Mori, K.; Glimcher, L.H.; Denko, N.C.; Giaccia, A.J.; et al. XBP1 is essential for survival under hypoxic conditions and is required for tumor growth. Cancer Res. 2004, 64, 5943–5947. [Google Scholar] [CrossRef]
  26. Romero, L.; Cao, H.; Hammond, E.; Giaccia, A.J.; Le, Q.T.; Koong, A.C. XBP1 is essential for survival under hypoxic conditions and is required for tumor growth. Int. J. Radiat. Oncol. Biol. Phys. 2004, 60, S192–S193. [Google Scholar] [CrossRef]
  27. Drogat, B.; Auguste, P.; Nguyen, D.T.; Bouchecareilh, M.; Pineau, R.; Nalbantoglu, J.; Kaufman, R.J.; Chevet, E.; Bikfalvi, A.; Moenner, M. IRE1 signaling is essential for ischemia-induced vascular endothelial growth factor-a expression and contributes to angiogenesis and tumor growth in vivo. Cancer Res. 2007, 67, 6700–6707. [Google Scholar] [CrossRef]
  28. Karar, J.; Dolt, K.S.; Pasha, M.A.Q. Endoplasmic reticulum stress response in murine kidney exposed to acute hypobaric hypoxia. FEBS Lett. 2008, 582, 2521–2526. [Google Scholar] [CrossRef]
  29. Cao, X.; He, Y.; Li, X.; Xu, Y.; Liu, X. The IRE1α-XBP1 pathway function in hypoxia-induced pulmonary vascular remodeling, is upregulated by quercetin, inhibits apoptosis and partially reverses the effect of quercetin in PASMCs. Am. J. Transl. Res. 2019, 11, 641–654. [Google Scholar]
  30. Hernansanz-Agustin, P.; Izquierdo-Alvarez, A.; Sanchez-Gomez, F.J.; Ramos, E.; Villa-Pina, T.; Lamas, S.; Bogdanova, A.; Martinez-Ruiz, A. Acute hypoxia produces a superoxide burst in cells. Free Radic. Biol. Med. 2014, 71, 146–156. [Google Scholar] [CrossRef]
  31. Chandel, N.S.; Maltepe, E.; Goldwasser, E.; Mathieu, C.E.; Simon, M.C.; Schumacker, P.T. Mitochondrial reactive oxygen species trigger hypoxia-induced transcription. Proc. Natl. Acad. Sci. USA 1998, 95, 11715–11720. [Google Scholar] [CrossRef] [PubMed]
  32. Livak, K.J.; Schmittgen, T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001, 25, 402–408. [Google Scholar] [CrossRef] [PubMed]
  33. Bakhashab, S.; Lary, S.; Ahmed, F.; Schulten, H.J.; Bashir, A.; Ahmed, F.W.; Al-Malki, A.L.; Jamal, H.S.; Gari, M.A.; Weaver, J.U. Reference genes for expression studies in hypoxia and hyperglycemia models in human umbilical vein endothelial cells. G3 2014, 4, 2159–2165. [Google Scholar] [CrossRef] [PubMed]
  34. Bartoszewski, R.; Moszynska, A.; Serocki, M.; Cabaj, A.; Polten, A.; Ochocka, R.; Dell’Italia, L.; Bartoszewska, S.; Kroliczewski, J.; Dabrowski, M.; et al. Primary endothelial cell-specific regulation of hypoxia-inducible factor (HIF)-1 and HIF-2 and their target gene expression profiles during hypoxia. FASEB J. 2019, 33, 7929–7941. [Google Scholar] [CrossRef] [PubMed]
  35. Kochan-Jamrozy, K.; Kroliczewski, J.; Moszynska, A.; Collawn, J.F.; Bartoszewski, R. miRNA networks modulate human endothelial cell adaptation to cyclic hypoxia. Cell Signal. 2019, 54, 150–160. [Google Scholar] [CrossRef] [PubMed]
  36. Bartoszewski, R.; Serocki, M.; Janaszak-Jasiecka, A.; Bartoszewska, S.; Kochan-Jamrozy, K.; Piotrowski, A.; Kroliczewski, J.; Collawn, J.F. miR-200b downregulates Kruppel Like Factor 2 (KLF2) during acute hypoxia in human endothelial cells. Eur. J. Cell Biol 2017, 96, 758–766. [Google Scholar] [CrossRef] [PubMed]
  37. Janaszak-Jasiecka, A.; Bartoszewska, S.; Kochan, K.; Piotrowski, A.; Kalinowski, L.; Kamysz, W.; Ochocka, R.J.; Bartoszewski, R.; Collawn, J.F. miR-429 regulates the transition between Hypoxia-Inducible Factor (HIF)1A and HIF3A expression in human endothelial cells. Sci. Rep. 2016, 6, 22775. [Google Scholar] [CrossRef]
  38. Bartoszewska, S.; Kochan, K.; Piotrowski, A.; Kamysz, W.; Ochocka, R.J.; Collawn, J.F.; Bartoszewski, R. The hypoxia-inducible miR-429 regulates hypoxia-inducible factor-1alpha expression in human endothelial cells through a negative feedback loop. FASEB J. 2015, 29, 1467–1479. [Google Scholar] [CrossRef]
  39. Hayashi, M.; Sakata, M.; Takeda, T.; Yamamoto, T.; Okamoto, Y.; Sawada, K.; Kimura, A.; Minekawa, R.; Tahara, M.; Tasaka, K.; et al. Induction of glucose transporter 1 expression through hypoxia-inducible factor 1 alpha under hypoxic conditions in trophoblast-derived cells. J. Endocrinol. 2004, 183, 145–154. [Google Scholar] [CrossRef]
  40. Forsythe, J.A.; Jiang, B.H.; Iyer, N.V.; Agani, F.; Leung, S.W.; Koos, R.D.; Semenza, G.L. Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1. Mol. Cell. Biol. 1996, 16, 4604–4613. [Google Scholar] [CrossRef]
  41. Bartoszewski, R.; Gebert, M.; Janaszak-Jasiecka, A.; Cabaj, A.; Kroliczewski, J.; Bartoszewska, S.; Sobolewska, A.; Crossman, D.K.; Ochocka, R.; Kamysz, W.; et al. Genome-wide mRNA profiling identifies RCAN1 and GADD45A as regulators of the transitional switch from survival to apoptosis during ER stress. FEBS J. 2019. [Google Scholar] [CrossRef]
  42. Pobre, K.F.R.; Poet, G.J.; Hendershot, L.M. The endoplasmic reticulum (ER) chaperone BiP is a master regulator of ER functions: Getting by with a little help from ERdj friends. J. Biol. Chem. 2019, 294, 2098–2108. [Google Scholar] [CrossRef]
  43. Hetz, C.; Papa, F.R. The Unfolded Protein Response and Cell Fate Control. Mol. Cell 2018, 69, 169–181. [Google Scholar] [CrossRef]
  44. Hetz, C. The unfolded protein response: Controlling cell fate decisions under ER stress and beyond. Nat. Rev. Mol. Cell Biol. 2012, 13, 89–102. [Google Scholar] [CrossRef]
  45. Nishitoh, H. CHOP is a multifunctional transcription factor in the ER stress response. J. Biochem. 2012, 151, 217–219. [Google Scholar] [CrossRef]
  46. Ghosh, R.; Lipson, K.L.; Sargent, K.E.; Mercurio, A.M.; Hunt, J.S.; Ron, D.; Urano, F. Transcriptional regulation of VEGF-A by the unfolded protein response pathway. PLoS ONE 2010, 5, e9575. [Google Scholar] [CrossRef]
  47. Pereira, E.R.; Liao, N.; Neale, G.A.; Hendershot, L.M. Transcriptional and post-transcriptional regulation of proangiogenic factors by the unfolded protein response. PLoS ONE 2010, 5. [Google Scholar] [CrossRef]
  48. Afonyushkin, T.; Oskolkova, O.V.; Philippova, M.; Resink, T.J.; Erne, P.; Binder, B.R.; Bochkov, V.N. Oxidized phospholipids regulate expression of ATF4 and VEGF in endothelial cells via NRF2-dependent mechanism: Novel point of convergence between electrophilic and unfolded protein stress pathways. Arter. Thromb. Vasc. Biol. 2010, 30, 1007–1013. [Google Scholar] [CrossRef]
  49. Pereira, E.R.; Frudd, K.; Awad, W.; Hendershot, L.M. Endoplasmic Reticulum (ER) Stress and Hypoxia Response Pathways Interact to Potentiate Hypoxia-inducible Factor 1 (HIF-1) Transcriptional Activity on Targets Like Vascular Endothelial Growth Factor (VEGF). J. Biol. Chem. 2014, 289, 3352–3364. [Google Scholar] [CrossRef]
  50. Cross, B.C.S.; Bond, P.J.; Sadowski, P.G.; Jha, B.K.; Zak, J.; Goodman, J.M.; Silverman, R.H.; Neubert, T.A.; Baxendale, I.R.; Ron, D.; et al. The molecular basis for selective inhibition of unconventional mRNA splicing by an IRE1-binding small molecule. Proc. Natl. Acad. Sci. USA 2012, 109, E869–E878. [Google Scholar] [CrossRef]
  51. Moenner, M.; Pluquet, O.; Bouchecareilh, M.; Chevet, E. Integrated endoplasmic reticulum stress responses in cancer. Cancer Res. 2007, 67, 10631–10634. [Google Scholar] [CrossRef]
  52. Manalo, R.V.M. Anastasis and the ER stress response: Solving the paradox of the unfolded protein response in cancer. Med Hypotheses 2017, 109, 25–27. [Google Scholar] [CrossRef]
  53. Vandewynckel, Y.P.; Laukens, D.; Geerts, A.; Bogaerts, E.; Paridaens, A.; Verhelst, X.; Janssens, S.; Heindryckx, F.; Van Vlierberghe, H. The Paradox of the Unfolded Protein Response in Cancer. Anticancer Res. 2013, 33, 4683–4694. [Google Scholar]
  54. Koumenis, C.; Wouters, B.G. “Translating” tumor hypoxia: Unfolded protein response (UPR)-dependent and UPR-independent pathways. Mol. Cancer Res. 2006, 4, 423–436. [Google Scholar] [CrossRef]
  55. Mujcic, H.; Rzymski, T.; Rouschop, K.M.A.; Koritzinsky, M.; Milani, M.; Harris, A.L.; Wouters, B.G. Hypoxic activation of the unfolded protein response (UPR) induces expression of the metastasis-associated gene LAMP3. Radiother. Oncol. 2009, 92, 450–459. [Google Scholar] [CrossRef]
  56. Obacz, J.; Avril, T.; Rubio-Patiño, C.; Bossowski, J.P.; Igbaria, A.; Ricci, J.E.; Chevet, E. Regulation of tumor-stroma interactions by the unfolded protein response. FEBS J. 2019, 286, 279–296. [Google Scholar] [CrossRef]
  57. Rouschop, K.M.A.; van den Beucken, T.; Dubois, L.; Niessen, H.; Bussink, J.; Savelkouls, K.; Keulers, T.; Mujcic, H.; Landuyt, W.; Voncken, J.W.; et al. The unfolded protein response protects human tumor cells during hypoxia through regulation of the autophagy genes MAP1LC3B and ATG5. J. Clin. Investig. 2010, 120, 127–141. [Google Scholar] [CrossRef]
  58. Muz, B.; de la Puente, P.; Azab, F.; Azab, A.K. The role of hypoxia in cancer progression, angiogenesis, metastasis, and resistance to therapy. Hypoxia 2015, 3, 83–92. [Google Scholar] [CrossRef]
  59. Nishida, N.; Yano, H.; Nishida, T.; Kamura, T.; Kojiro, M. Angiogenesis in cancer. Vasc. Health Risk Manag. 2006, 2, 213–219. [Google Scholar] [CrossRef]
  60. Sun, L.L.; Chen, C.M.; Zhang, J.; Wang, J.; Yang, C.Z.; Lin, L.Z. Glucose-Regulated Protein 78 Signaling Regulates Hypoxia-Induced Epithelial-Mesenchymal Transition in A549 Cells. Front. Oncol. 2019, 9. [Google Scholar] [CrossRef]
  61. Song, M.S.; Park, Y.K.; Lee, J.H.; Park, K. Induction of glucose-regulated protein 78 by chronic hypoxia in human gastric tumor cells through a protein kinase C-epsilon/ERK/AP-1 signaling cascade. Cancer Res. 2001, 61, 8322–8330. [Google Scholar]
  62. Koong, A.C.; Auger, E.A.; Chen, E.Y.; Giaccia, A.J. The Regulation of Grp78 and Messenger-Rna Levels by Hypoxia Is Modulated by Protein-Kinase-C Activators and Inhibitors. Radiat. Res. 1994, 138, S60–S63. [Google Scholar] [CrossRef]
  63. Delbrel, E.; Soumare, A.; Naguez, A.; Label, R.; Bernard, O.; Bruhat, A.; Fafournoux, P.; Tremblais, G.; Marchant, D.; Gille, T.; et al. HIF-1 alpha triggers ER stress and CHOP-mediated apoptosis in alveolar epithelial cells, a key event in pulmonary fibrosis. Sci. Rep. 2018, 8. [Google Scholar] [CrossRef]
  64. Xie, P.; Duan, Y.C.; Guo, X.Z.; Hu, L.N.; Yu, M.H. SalA Attenuates Hypoxia-Induced Endothelial Endoplasmic Reticulum Stress and Apoptosis via Down-Regulation of VLDL Receptor Expression. Cell. Physiol. Biochem. 2015, 35, 17–28. [Google Scholar] [CrossRef]
  65. Hourihan, J.M.; Moronetti Mazzeo, L.E.; Fernandez-Cardenas, L.P.; Blackwell, T.K. Cysteine Sulfenylation Directs IRE-1 to Activate the SKN-1/Nrf2 Antioxidant Response. Mol. Cell 2016, 63, 553–566. [Google Scholar] [CrossRef]
  66. Rutkowski, D.T.; Arnold, S.M.; Miller, C.N.; Wu, J.; Li, J.; Gunnison, K.M.; Mori, K.; Akha, A.A.S.; Raden, D.; Kaufman, R.J. Adaptation to ER stress is mediated by differential stabilities of pro-survival and pro-apoptotic mRNAs and proteins. PLoS Biol. 2006, 4, 2024–2041. [Google Scholar] [CrossRef]
  67. Chen, Y.N.; Brandizzi, F. IRE1: ER stress sensor and cell fate executor. Trends Cell Biol. 2013, 23, 547–555. [Google Scholar] [CrossRef]
Biomolecules 10 00895 g001
Figure 1. Primary HUVECs were exposed to hypoxia (0.9% O2) for up to 24 h. (A) HIF-1α protein levels were evaluated at the specified time points by Western Blotting, normalized to β-actin and total protein levels and related to the time of hypoxic exposure. The densitometry analysis is representing two independent experiments (* p < 0.05 was considered significant). (B) GLUT1 (SLC2A1), (C) VEGFA, (D) BiP (HSPA5) and (E) CHOP (DDIT3) mRNA levels were quantified by quantitative real-time PCR and normalized to 18S and RPLP0 rRNA levels and expressed as a fold change over normoxic samples. Data represent the mean ± SEM of four independent experiments.
Figure 1. Primary HUVECs were exposed to hypoxia (0.9% O2) for up to 24 h. (A) HIF-1α protein levels were evaluated at the specified time points by Western Blotting, normalized to β-actin and total protein levels and related to the time of hypoxic exposure. The densitometry analysis is representing two independent experiments (* p < 0.05 was considered significant). (B) GLUT1 (SLC2A1), (C) VEGFA, (D) BiP (HSPA5) and (E) CHOP (DDIT3) mRNA levels were quantified by quantitative real-time PCR and normalized to 18S and RPLP0 rRNA levels and expressed as a fold change over normoxic samples. Data represent the mean ± SEM of four independent experiments.
Biomolecules 10 00895 g001
Biomolecules 10 00895 g002
Figure 2. Primary HUVECs were exposed to hypoxia (0.9% O2) for up to 24 h. (A) IRE1 (ERN1), (B) XBP1 (total) and (C) XBP1s (spliced) mRNA levels were quantified by quantitative real-time PCR and normalized to 18S and RPLP0 rRNA levels and expressed as a fold change over normoxic samples. Data represent the mean ± SEM of four independent experiments (* p < 0.05 was considered significant).
Figure 2. Primary HUVECs were exposed to hypoxia (0.9% O2) for up to 24 h. (A) IRE1 (ERN1), (B) XBP1 (total) and (C) XBP1s (spliced) mRNA levels were quantified by quantitative real-time PCR and normalized to 18S and RPLP0 rRNA levels and expressed as a fold change over normoxic samples. Data represent the mean ± SEM of four independent experiments (* p < 0.05 was considered significant).
Biomolecules 10 00895 g002
Biomolecules 10 00895 g003
Figure 3. IRE1 knockdown affects HIF1α protein level in hypoxia in HUVECs. (A) IRE1 mRNA levels after IRE1 knockdown. (B) HIF-1α protein levels after IRE1 knockdown in normoxia and hypoxia were evaluated by Western Blotting, normalized to β-actin and total protein levels and related to hypoxia (CTRL). The densitometry analysis is representing two independent experiments (* p < 0.05 was considered significant). (C) HIF1A mRNA levels after IRE1 knockdown. (A) and (C) mRNA levels were quantified by quantitative real-time PCR, normalized to 18S and RPLP0 rRNA levels and expressed as fold changes over normoxic samples. Data represent the mean ± SEM of two independent experiments.
Figure 3. IRE1 knockdown affects HIF1α protein level in hypoxia in HUVECs. (A) IRE1 mRNA levels after IRE1 knockdown. (B) HIF-1α protein levels after IRE1 knockdown in normoxia and hypoxia were evaluated by Western Blotting, normalized to β-actin and total protein levels and related to hypoxia (CTRL). The densitometry analysis is representing two independent experiments (* p < 0.05 was considered significant). (C) HIF1A mRNA levels after IRE1 knockdown. (A) and (C) mRNA levels were quantified by quantitative real-time PCR, normalized to 18S and RPLP0 rRNA levels and expressed as fold changes over normoxic samples. Data represent the mean ± SEM of two independent experiments.
Biomolecules 10 00895 g003
Biomolecules 10 00895 g004
Figure 4. IRE1α inhibition by 4µ8C in hypoxia results in HIF-1α protein reduction in HUVECs. (A) Structural formula of 4µ8C. (B) HIF-1α protein levels after IRE1α inhibition by 4µ8C in normoxia and hypoxia were evaluated by Western Blotting, normalized to β-actin and total protein levels and related to hypoxia (CTRL). The densitometry analysis is representing two independent experiments (* p < 0.05 was considered significant). (C) HIF1A, (D) XBP1s (spliced) and (E) XBP1 (total) mRNA levels were quantified by quantitative real-time PCR, normalized to 18S and RPLP0 rRNA levels and expressed as a fold change over normoxic samples. Data represent the mean ± SEM of two independent experiments.
Figure 4. IRE1α inhibition by 4µ8C in hypoxia results in HIF-1α protein reduction in HUVECs. (A) Structural formula of 4µ8C. (B) HIF-1α protein levels after IRE1α inhibition by 4µ8C in normoxia and hypoxia were evaluated by Western Blotting, normalized to β-actin and total protein levels and related to hypoxia (CTRL). The densitometry analysis is representing two independent experiments (* p < 0.05 was considered significant). (C) HIF1A, (D) XBP1s (spliced) and (E) XBP1 (total) mRNA levels were quantified by quantitative real-time PCR, normalized to 18S and RPLP0 rRNA levels and expressed as a fold change over normoxic samples. Data represent the mean ± SEM of two independent experiments.
Biomolecules 10 00895 g004
Biomolecules 10 00895 g005
Figure 5. XBP1 knockdown in hypoxia in HUVECs. (A) XBP1s (spliced) mRNA levels after XBP1 knockdown. (B) HIF-1α protein levels after XBP1 knockdown in normoxia and hypoxia were evaluated by Western Blotting, normalized to β-actin and total protein levels and related to hypoxia (CTRL). The densitometry analysis is representing two independent experiments (* p < 0.05 was considered significant). (C) HIF1A mRNA levels after XBP1 knockdown. The mRNA levels were quantified by quantitative real-time PCR and normalized to 18S and RPLP0 rRNA levels and expressed as a fold change over normoxic samples. Data represent the mean ± SEM of two independent experiments (* p < 0.05 was considered significant).
Figure 5. XBP1 knockdown in hypoxia in HUVECs. (A) XBP1s (spliced) mRNA levels after XBP1 knockdown. (B) HIF-1α protein levels after XBP1 knockdown in normoxia and hypoxia were evaluated by Western Blotting, normalized to β-actin and total protein levels and related to hypoxia (CTRL). The densitometry analysis is representing two independent experiments (* p < 0.05 was considered significant). (C) HIF1A mRNA levels after XBP1 knockdown. The mRNA levels were quantified by quantitative real-time PCR and normalized to 18S and RPLP0 rRNA levels and expressed as a fold change over normoxic samples. Data represent the mean ± SEM of two independent experiments (* p < 0.05 was considered significant).
Biomolecules 10 00895 g005
Biomolecules 10 00895 g006
Figure 6. IRE1α inhibition by 4µ8C in hypoxia (6 h) results in HIF-1α protein reduction in (A) HMVECs-C and (B) HAECs. HIF-1α protein levels after IRE1α inhibition by 4µ8C in normoxia and hypoxia were evaluated by Western Blotting, normalized to β-actin and total protein levels and related to hypoxia (CTRL). The densitometry analysis is representing two independent experiments (* p < 0.05 was considered significant).
Figure 6. IRE1α inhibition by 4µ8C in hypoxia (6 h) results in HIF-1α protein reduction in (A) HMVECs-C and (B) HAECs. HIF-1α protein levels after IRE1α inhibition by 4µ8C in normoxia and hypoxia were evaluated by Western Blotting, normalized to β-actin and total protein levels and related to hypoxia (CTRL). The densitometry analysis is representing two independent experiments (* p < 0.05 was considered significant).
Biomolecules 10 00895 g006

Share and Cite

MDPI and ACS Style

Moszyńska, A.; Collawn, J.F.; Bartoszewski, R. IRE1 Endoribonuclease Activity Modulates Hypoxic HIF-1α Signaling in Human Endothelial Cells. Biomolecules 2020, 10, 895. https://doi.org/10.3390/biom10060895

AMA Style

Moszyńska A, Collawn JF, Bartoszewski R. IRE1 Endoribonuclease Activity Modulates Hypoxic HIF-1α Signaling in Human Endothelial Cells. Biomolecules. 2020; 10(6):895. https://doi.org/10.3390/biom10060895

Chicago/Turabian Style

Moszyńska, Adrianna, James F. Collawn, and Rafal Bartoszewski. 2020. "IRE1 Endoribonuclease Activity Modulates Hypoxic HIF-1α Signaling in Human Endothelial Cells" Biomolecules 10, no. 6: 895. https://doi.org/10.3390/biom10060895

APA Style

Moszyńska, A., Collawn, J. F., & Bartoszewski, R. (2020). IRE1 Endoribonuclease Activity Modulates Hypoxic HIF-1α Signaling in Human Endothelial Cells. Biomolecules, 10(6), 895. https://doi.org/10.3390/biom10060895

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop